Nicholas Opalich is a visionary leader in the pharmaceutical and healthcare industry, known for founding Strategica Health Partners in 2002 in Cleveland, Ohio. This private consultancy specializes in healthcare services and pharmaceutical solutions, where Opalich, as CEO, managed critical aspects such as contracting, drug procurement, and pharmacy relations. His expertise and guidance were pivotal in advancing the organization's role as an independent distributor and medical model developer, benefitting a range of large-scale clients and public healthcare companies.

In 2013, while retaining Nicholas's position as a managing partner at Strategica, he broadened his professional scope to include serving as the CEO of InfinityRx between 2021 and 2022. InfinityRx, located in New Hyde Park, New York, focuses on administering programs for pharmaceutical manufacturers, encompassing a spectrum from pre-launch activities to consumer engagement.

His career began with a ground-breaking venture into specialty infusion services through Home Infusion Systems, which he established in 1982 and led until 1987. He then transitioned to founding Continental Health Care in 1988. Additionally, his consultancy role with Capital Rx, Inc. in New York City saw him collaborate on a significant healthcare system project, expanding into specialty pharmaceutical and mail-order pharmacy sectors.

Academically, Opalich's roots trace back to David N. Myers University, where he earned his Bachelor of Science in Business in 1974. A proactive student, he engaged with the American Society of Marketing and Management, earning dual bachelor's degrees in pharmacy and business management from Meyers College that same year.

Nicholas Opalich has recently joined NHPCO, the National Hospice and Palliative Care Organization, as the Founder and CEO of HospiceChoice Rx. Visit www.nhpco.org.